TMCnet News

Global Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors Pipeline Insights Report 2016 - Research and Markets
[July 28, 2016]

Global Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors Pipeline Insights Report 2016 - Research and Markets


Research and Markets has announced the addition of the "Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors - Pipeline Insights, 2016" report to their offering.

"Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors - Pipeline Insights, 2016" provides in depth insights on the pipeline drugs and their development activities around the Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors.

The report also assesses the Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors therapeutics by Monotherapy, Combination products, molecule type and Route of Administrtion.



Scope

  • The report provides competitive pipeline landscape of Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Tryptophan Hydroxylase (TPH or Tryptophan 5-Monooxygenase) Inhibitors and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:


  1. Overview
  2. Pipeline Therapeutics
  3. Therapeutics under Development by Companies
  4. Filed and Phase III Products
  5. Comparative Analysis
  6. Phase II Products
  7. Comparative Analysis
  8. Phase I and IND Filed Products
  9. Comparative Analysis
  10. Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Discontinued Products
  19. Dormant Products
  20. Companies Involved in Therapeutics Development

For more information visit http://www.researchandmarkets.com/research/hbt43p/tryptophan


[ Back To TMCnet.com's Homepage ]